Internal Medicine, Pulmonary Disease · Kenosha, WI
NPI
1760439608
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
6308 8th Ave
Kenosha, WI, 53143
Phone (262) 653-5360
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
1,021 services
Medicare patients, 2024
561
Average age 72
Drug cost, 2024
$1.5M
3,512 prescriptions
Company payments, 2025
$48K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alfred M Habel was code 99213 (office e&m - established), 499 times for 371 patients. In total Alfred M Habel billed 1,021 services in 17 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 499 | 371 | $61.84 | $31K |
| 99214 Office E&M - Established | Office | 248 | 195 | $74.48 | $18K |
| 99203 Office E&M - New | Office | 51 | 51 | $72.74 | $3,710 |
| 95806 Sleep Study | Office | 40 | 40 | $30.30 | $1,212 |
| 94729 Pulmonary Function Testing | Office | 33 | 33 | $6.21 | $205 |
| 94727 Pulmonary Function Testing | Office | 33 | 33 | $8.22 | $271 |
| 99204 Office E&M - New | Office | 26 | 26 | $104.61 | $2,720 |
| 95811 Sleep Study | Office | 24 | 24 | $91.34 | $2,192 |
| 94010 Pulmonary Function Testing | Office | 20 | 20 | $5.72 | $114 |
| 95810 Sleep Study | Office | 18 | 18 | $86.40 | $1,555 |
| 94060 Pulmonary Function Testing | Office | 16 | 16 | $7.23 | $116 |
By year: 2022 $104K for 1,533 services; 2023 $85K for 1,288 services; 2024 $62K for 1,021 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alfred M Habel prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 327 prescriptions and refills. In total Alfred M Habel wrote 3,512 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 327 | 473 | 86 | $9,140 |
| Trazodone Hcl Generic | 295 | 651 | 72 | $5,420 |
| Prednisone Generic | 163 | 241 | 83 | $811 |
| Alprazolam Generic | 147 | 161 | 27 | $647 |
| Breo Ellipta Fluticasone/Vilanterol | 143 | 181 | 24 | $69K |
| Clonazepam Generic | 139 | 163 | 29 | $1,162 |
| Bupropion Xl Bupropion Hcl | 138 | 298 | 40 | $3,135 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 126 | 155 | 20 | $96K |
| Symbicort Budesonide/Formoterol Fumarate | 113 | 184 | 35 | $40K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 110 | 172 | 25 | $22K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 103 | 214 | 20 | $2,446 |
| Sertraline Hcl Generic | 93 | 209 | 22 | $535 |
| Quetiapine Fumarate Generic | 81 | 145 | 16 | $1,176 |
| Montelukast Sodium Generic | 79 | 226 | 25 | $857 |
| Temazepam Generic | 73 | 91 | 24 | $887 |
Brand drugs: 1,231 claims; generic drugs: 2,281 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alfred M Habel $48K ($48K in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $21K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 47 | $21K |
| GlaxoSmithKline, LLC. GSK | 36 | $19K |
| Viatris Specialty LLC | 15 | $5,987 |
| Genzyme Corporation SNY | 11 | $437 |
| Jazz Pharmaceuticals Inc. JAZZ | 10 | $366 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $297 |
| Verona Pharma, Inc. VRNA | 6 | $205 |
| Harmony Biosciences LLC HRMY | 4 | $107 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $96.7 |
| Resmed Corp RMD | 2 | $76.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.